Microglia: Active sensor and versatile effector cells in the normal and pathologic brain

Nature Neuroscience

Volumn 10, Issue 11, 2007, Pages 1387-1394

  Hanisch, Uwe Karsten ^a   Kettenmann, Helmut ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID;

ALZHEIMER DISEASE; BONE MARROW CELL; BRAIN; CELL ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CELL HETEROGENEITY; CELL POPULATION; CELL TRANSFORMATION; CENTRAL NERVOUS SYSTEM; DISEASE COURSE; DISEASE EXACERBATION; EFFECTOR CELL; GENETIC TRANSCRIPTION; HUMAN; ISCHEMIA; MACROPHAGE; MICROGLIA; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SENSOR; TURNOVER TIME;

ANIMALS; BRAIN; BRAIN DISEASES; HUMANS; MICROGLIA; MODELS, BIOLOGICAL;

EID: 35548986304     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1997     Document Type: Review

References (100)

1. Kim, S.U. & de Vellis, J. Microglia in health and disease. J. Neurosci. Res. 81, 302-313 (2005).
2. Denes, A. et al. Proliferating resident microglia after focal cerebral ischaemia in mice. J. Cereb. Blood Flow Metab., published online 18 April 2007 (doi:10.1038/sj.jcbfm.9600495).
3. Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318 (2005).
4. Davalos, D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8, 752-758 (2005).
5. Haynes, S.E. et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9, 1512-1519 (2006).
6. Kreutzberg, G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318 (1996).
7. Nakamura, Y. Regulating factors for microglial activation. Biol. Pharm. Bull. 25, 945-953 (2002).
8. van Rossum, D. & Hanisch, U.K. Microglia. Metab. Brain Dis. 19, 393-411 (2004).
9. Block, M.L., Zecca, L. & Hong, J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57-69 (2007).
10. Olson, J.K. & Miller, S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173, 3916-3924 (2004).
11. Trinchieri, G. & Sher, A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7, 179-190 (2007).
12. Hoek, R.M. et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290, 1768-1771 (2000).
13. Wright, G.J. et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13, 233-242 (2000).
14. Cardona, A.E. et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917-924 (2006).
15. Bessis, A., Bechade, C., Bernard, D. & Roumier, A. Microglial control of neuronal death and synaptic properties. Glia 55, 233-238 (2007).
16. Hamerman, J.A. et al. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177, 2051-2055 (2006).
17. Färber, K. & Kettenmann, H. Purinergic signaling and microglia. Pflugers Arch. 452, 615-621 (2006).
18. Pocock, J.M. & Kettenmann, H. Neurotransmitter receptors on microglia. Trends Neurosci. (in the press).
19. Hanisch, U.K. et al. The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls. Eur. J. Immunol. 31, 2104-2115 (2001).
20. Häusler, K.G. et al. Interferon-γ differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur. J. Neurosci. 16, 2113-2122 (2002).
21. Magnus, T., Chan, A., Grauer, O., Toyka, K.V. & Gold, R. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J. Immunol. 167, 5004-5010 (2001).
22. Liu, Y. et al. Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species. J. Neurosci. 26, 12904-12913 (2006).
23. Butovsky, O. et al. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J. Clin. Invest. 116, 905-915 (2006).
24. Butovsky, O. et al. Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neurosci. 31, 149-160 (2006).
25. Butovsky, O., Talpalar, A.E., Ben-Yaakov, K. & Schwartz, M. Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective. Mol. Cell. Neurosci. 29, 381-393 (2005).
26. Ziv, Y. et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 9, 268-275 (2006).
27. Glanzer, J.G. et al. Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation. J. Neurochem. 3, 627-645 (2007).
28. Kitamura, Y., Taniguchi, T., Kimura, H., Nomura, Y. & Gebicke-Haerter, P.J. Interleukin-4-inhibited mRNA expression in mixed rat glial and in isolated microglial cultures. J. Neuroimmunol. 106, 95-104 (2000).
29. Yang, M.S. et al. Interleukin-13 and -4 induce death of activated microglia. Glia 38, 273-280 (2002).
30. Serhan, C.N. & Savill, J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191-1197 (2005).
31. Kim, H.J. et al. Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis. J. Immunol. 172, 7144-7153 (2004).
32. Boucsein, C. et al. Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro. Eur. J. Neurosci. 17, 2267-2276 (2003).
33. Stout, R.D. & Suttles, J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76, 509-513 (2004).
34. Stout, R.D. et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342-349 (2005).
35. Porcheray, F. et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142, 481-489 (2005).
36. Schwartz, M., Butovsky, O., Bruck, W. & Hanisch, U.K. Microglial phenotype: is the commitment reversible? Trends Neurosci. 29, 68-74 (2006).
37. Rezaie, P. & Male, D. Mesoglia & microglia - a historical review of the concept of mononuclear phagocytes within the central nervous system. J. Hist. Neurosci. 11, 325-374 (2002).
38. Chan, W.Y., Kohsaka, S. & Rezaie, P. The origin and cell lineage of microglia: new concepts. Brain Res. Rev. 53, 344-354 (2007).
39. Gordon, S. & Taylor, P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964 (2005).
40. Lawson, L.J., Perry, V.H. & Gordon, S. Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48, 405-415 (1992).
41. Ladeby, R. et al. Microglial cell population dynamics in the injured adult central nervous system. Brain Res. Brain Res. Rev. 48, 196-206 (2005).
42. Flügel, A., Bradl, M., Kreutzberg, G.W. & Graeber, M.B. Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy. J. Neurosci. Res. 66, 74-82 (2001).
43. Djukic, M. et al. Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain 129, 2394-2403 (2006).
44. Priller, J. et al. Early and rapid engraftment of bone marrow-derived microglia in scrapie. J. Neurosci. 26, 11753-11762 (2006).
45. Xu, H., Chen, M., Mayer, E.J., Forrester, J.V. & Dick, A.D. Turnover of resident retinal microglia in the normal adult mouse. Glia 55, 1189-1198 (2007).
46. Bechmann, I. et al. Turnover of rat brain perivascular cells. Exp. Neurol. 168, 242-249 (2001).
47. Bechmann, I. et al. Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages. Eur. J. Neurosci. 14, 1651-1658 (2001).
48. Streit, W.J. Microglial senescence: does the brain's immune system have an expiration date? Trends Neurosci. 29, 506-510 (2006).
49. Sierra, A., Gottfried-Blackmore, A.C., McEwen, B.S. & Bulloch, K. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55, 412-424 (2007).
50. Thomas, W.E. Brain macrophages: on the role of pericytes and perivascular cells. Brain Res. Brain Res. Rev. 31, 42-57 (1999).
51. Binstadt, B.A. et al. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat. Immunol. 7, 284-292 (2006).
52. Galea, I., Bechmann, I. & Perry, V.H. What is immune privilege (not)? Trends Immunol. 28, 12-18 (2007).
53. Polazzi, E. & Contestabile, A. Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev. Neurosci. 13, 221-242 (2002).
54. Ren, L., Lubrich, B., Biber, K. & Gebicke-Haerter, P.J. Differential expression of inflammatory mediators in rat microglia cultured from different brain regions. Brain Res. Mol. Brain Res. 65, 198-205 (1999).
55. Elkabes, S., Cicco-Bloom, E.M. & Black, I.B. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 16, 2508-2521 (1996).
56. Sriram, K. et al. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-α. FASEB J. 20, 670-682 (2006).
57. Kuwabara, Y. et al. Two populations of microglial cells isolated from rat primary mixed glial cultures. J. Neurosci. Res. 73, 22-30 (2003).
58. Wirenfeldt, M. et al. Reactive microgliosis engages distinct responses by microglial subpopulations after minor central nervous system injury. J. Neurosci. Res. 82, 507-514 (2005).
59. Levy, O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7, 379-390 (2007).
60. Jack, C., Ruffini, F., Bar-Or, A. & Antel, J.P. Microglia and multiple sclerosis. J. Neurosci. Res. 81, 363-373 (2005).
61. Huitinga, I., van Rooijen, N., de Groot, C.J., Uitdehaag, B.M. & Dijkstra, C.D. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172, 1025-1033 (1990).
62. Heppner, F.L. et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11, 146-152 (2005).
63. Kotter, M.R., Zhao, C., van Rooijen, N. & Franklin, R.J.M. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol. Dis. 18, 166-175 (2005).
64. Stadelmann, C. et al. BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125, 75-85 (2002).
65. Bartnik, B.L., Juurlink, B.H. & Devon, R.M. Macrophages: their myelinotrophic or neurotoxic actions depend upon tissue oxidative stress. Mult. Scler. 6, 37-42 (2000).
66. Makranz, C. et al. Phosphatidylinositol 3-kinase, phosphoinositide-specific phospholipase-Cγ and protein kinase-C signal myelin phagocytosis mediated by complement receptor-3 alone and combined with scavenger receptor-AI/II in macrophages. Neurobiol. Dis. 15, 279-286 (2004).
67. Filbin, M.T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 4, 703-713 (2003).
68. Reichert, F. & Rotshenker, S. Complement-receptor-3 and scavenger-receptor-AI/II mediated myelin phagocytosis in microglia and macrophages. Neurobiol. Dis. 12, 65-72 (2003).
69. Liu, B. Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease. AAPS J. 8, E606-E621 (2006).
70. Mount, M.P. et al. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J. Neurosci. 27, 3328-3337 (2007).
71. Qian, L., Hong, J.S. & Flood, P.M. Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10. J. Neural Transm. Suppl. 367-371 (2006).
72. Simard, A.R. & Rivest, S. Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J. 18, 998-1000 (2004).
73. Majumdar, A. et al. Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol. Biol. Cell 18, 1490-1496 (2007).
74. El Khoury, J. et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13, 432-438 (2007).
75. Takata, K. et al. Microglial transplantation increases amyloid-β clearance in Alzheimer model rats. FEBS Lett. 581, 475-478 (2007).
76. Koenigsknecht-Talboo, J. & Landreth, G.E. Microglial phagocytosis induced by fibrillar β-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J. Neurosci. 25, 8240-8249 (2005).
77. Fan, R. et al. Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J. Neurosci. 27, 3057-3063 (2007).
78. Nathan, C. et al. Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J. Exp. Med. 202, 1163-1169 (2005).
79. Ramirez, B.G., Blázquez, C., Gómez del Pulgar, T., Guzmán, M. & de Ceballos, M.L. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J. Neurosci. 25, 1904-1913 (2005).
80. Lyons, S.A. et al. Distinct physiologic properties of microglia and blood-borne cells in rat brain slices after permanent middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 20, 1537-1549 (2000).
81. Lalancette-Hebert, M., Gowing, G., Simard, A., Weng, Y.C. & Kriz, J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27, 2596-2605 (2007).
82. Imai, F. et al. Neuroprotective effect of exogenous microglia in global brain ischemia. J. Cereb. Blood Flow Metab. 27, 488-500 (2007).
83. Kitamura, Y. et al. Intracerebroventricular injection of microglia protects against focal brain ischemia. J. Pharmacol. Sci. 94, 203-206 (2004).
84. Glezer, I., Simard, A.R. & Rivest, S. Neuroprotective role of the innate immune system by microglia. Neuroscience 147, 867-883 (2007).
85. Persson, M., Brantefjord, M., Hansson, E. & Ronnback, L. Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF-α. Glia 51, 111-120 (2005).
86. Shaked, I. et al. Protective autoimmunity: interferon-γ enables microglia to remove glutamate without evoking inflammatory mediators. J. Neurochem. 92, 997-1009 (2005).
87. Markovic, D.S., Glass, R., Synowitz, M., Rooijen, N. & Kettenmann, H. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J. Neuropathol. Exp. Neurol. 64, 754-762 (2005).
88. Sliwa, M. et al. The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A. Brain 130, 476-489 (2007).
89. Synowitz, M. et al. A1 adenosine receptors in microglia control glioblastoma-host interaction. Cancer Res. 66, 8550-8557 (2006).
90. Marin-Teva, J.L. et al. Microglia promote the death of developing Purkinje cells. Neuron 41, 535-547 (2004).
91. Monje, M.L., Toda, H. & Palmer, T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 1760-1765 (2003).
92. Ekdahl, C.T., Claasen, J.H., Bonde, S., Kokaia, Z. & Lindvall, O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. USA 100, 13632-13637 (2003).
93. Kempermann, G. & Neumann, H. Neuroscience. Microglia: the enemy within? Science 302, 1689-1690 (2003).
94. Yokoyama, A., Yang, L., Itoh, S., Mori, K. & Tanaka, J. Microglia, a potential source of neurons, astrocytes, and oligodendrocytes. Glia 45, 96-104 (2004).
95. Yokoyama, A., Sakamoto, A., Kameda, K., Imai, Y. & Tanaka, J. NG2 proteoglycan-expressing microglia as multipotent neural progenitors in normal and pathologic brains. Glia 53, 754-768 (2006).
96. Butovsky, O., Bukshpan, S., Kunis, G., Jung, S. & Schwartz, M. Microglia can be induced by IFN-γ or IL-4 to express neural or dendritic-like markers. Mol. Cell. Neurosci. 35, 490-500 (2007).
97. Eglitis, M.A. & Mezey, E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. USA 94, 4080-4085 (1997).
98. Trapp, B.D. et al. Evidence for synaptic stripping by cortical microglia. Glia 55, 360-368 (2007).
99. Cullheim, S. & Thams, S. The microglial networks of the brain and their role in neuronal network plasticity after lesion. Brain Res. Rev. 55, 89-96 (2007).
100. Rappert, A. et al. CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J. Neurosci. 24, 8500-8509 (2004).